MURA Archived Articles
Mural Oncology plc (NASDAQ:MURA): Capitalizing on the Potential of Cytokine-Based Immunotherapies
Published on March 13, 2025
Mural Oncology plc Reports First Quarter 2024 Financial Results and Provides Business Update
Published on September 24, 2024